Medicare cuts funds for cancer treatments
Boston Globe, December 7, 2007
New Medicare rules for a small but promising class of cancer drugs may cause thousands of lymphoma patients to lose access to the treatment. The companies that make the drugs, and patient advocates, say the changes will cut reimbursement for the medicines and cause many hospitals to stop offering the treatments.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- How Chargemaster Data May Affect Hospital Revenue
- Insurer's App Aims to Lower Healthcare Costs, Securely
- Uncompensated Care Faces a Double Hit in Some States
- ED Physicians Key to Half of Hospital Admissions
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Hospital Pricing Transparency a Marketing Game Changer
